|
Re: FDA PANEL recommends perjeta be aproved for Early breast cancer
I am so excited to hear this news. For every 1000 women who receive neoadjuvant Perjeta with the Herceptin and chemo, 178 more will reach a complete response.
This almost doubles the complete response rate with Herceptin and neoadjuvant chemo.
I'm shaking my pom poms here! Go Roche! Go FDA!
When the FDA approval comes through I think I'll pop the champagne.
|